Is Johnson & Johnson Stock Outperforming the Nasdaq?

With a market cap of $592.4 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a global healthcare company engaged in the research, development, manufacturing, and sale of a broad range of medical products worldwide. The company serves patients and healthcare professionals through hospitals, wholesalers, retailers, and clinics around the world. Companies valued at $200 billion or more are generally considered “mega-cap” stocks and Johnson & Johnson fits this criterion perfectly. It opera ...